Share Name Share Symbol Market Type Share ISIN Share Description
Plant Impact LSE:PIM London Ordinary Share GB00B1F4K366 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 51.50p 51.00p 52.00p 52.00p 51.50p 51.50p 150,480.00 12:39:36
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 7.2 -1.2 -0.9 - 42.07

Plant Impact (PIM) Latest News

More Plant Impact News
Plant Impact Takeover Rumours

Plant Impact (PIM) Share Charts

1 Year Plant Impact Chart

1 Year Plant Impact Chart

1 Month Plant Impact Chart

1 Month Plant Impact Chart

Intraday Plant Impact Chart

Intraday Plant Impact Chart

Plant Impact (PIM) Discussions and Chat

Plant Impact Forums and Chat

Date Time Title Posts
23/2/201710:20Plant Impact - Increasing crop capacity1,000.00
09/1/201722:21Attended AGM..1.00
14/5/201414:15PIM - Built on sand?4.00
17/9/201318:20PLANT IMPACT : transforming agriculture with eco-friendly solutions1,661.00
15/12/201108:26Plant Impact plc606.00

Add a New Thread

Plant Impact (PIM) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Plant Impact trades in real-time

Plant Impact (PIM) Top Chat Posts

Plant Impact Daily Update: Plant Impact is listed in the Chemicals sector of the London Stock Exchange with ticker PIM. The last closing price for Plant Impact was 51.50p.
Plant Impact has a 4 week average price of 48.40p and a 12 week average price of 47.34p.
The 1 year high share price is 59.75p while the 1 year low share price is currently 43.50p.
There are currently 81,695,400 shares in issue and the average daily traded volume is 63,062 shares. The market capitalisation of Plant Impact is Ā£42,073,131.
glenglen: I am new to this investing lark and will admit I know little about soybean production/exports and related topics. Bought into PIM in 2015 after reading a good report on it- the company was going places so I thought I will get "in on the action" - Took a punt in effect. All I need to know is where is this company going for me as a shareholder? Will the share price ever increase. For 2 years I have read all these "positives" which is good but share price drops and seems to merely hover round 45p - 50p My risk/fault/whatever I fully accept but will there ever be a bonanza coming our way? Is it the intention (long term or otherwise) that Bayer (or someone of the same ilk) will come along and buy them - hopefully offering more than 50p? Long term I do not have a problem with but can someone shed some light on how long that term might just be?
horace_h: Looking at the "viciouscircle" posts, he/she was "the large shareholder that got out in June 2009 with a price he/she was happy with". That would be (at best) the 45p price that has prompted this re-appearance as the price has fallen back from last year's high of circa 65p. No surprise that he/she didn't appear at THAT point to say that he/she had been wrong and should have held. So what kind of keyboard warrior nurses that sort of six year old angst? What kind of warrior (groan) comes back after such a time to give an articulate damnation of Plant Impact from his/her point of view? In virtually the same style as Agextpert on an earlier insidious thread. Marks out of 10? I really don't care whether it is David Marks or not - if it is then he clearly hasn't learned anything from his dismissal in 2009 and one would wonder why HE doesn't stick with what he was clearly very good at. Corporations such as Bayer, Syngenta etc. do not form the type of relationship John Brubaker and David Jones have developed unless they are true professionals. Going back to making mischief in "chat rooms" would not bode well for Levity's future. Regardless of his/her identity, perhaps our hero will tell us what's so great about Levity of why - like Agextpert, he/she has returned after six years to save us all for ourselves. I hold one other AIM share - Reneuron - and on of the various boards (LSE, III etc.) there is a character called Fredd1eBoy. This apparently nice Chap has been promoting the share with unbelievable optimism and "the great breakthrough to our fortune has been just around the next RNS" for years now. It's just as ludicrous as some character coming back after six years or, to a lesser extent, dear old MTHead who hasn't said anything positive since 2011. The share price hasn't collapsed as a result of the patent application - as Timbo says this is not the first time this has happened. If anything, it has fallen back because the Wheat product has not yet arrived - that IS a disappointment to me but no reason to sell or worry. But the day I listen to purely positive Rampers or purely negative mischief makers (I do have other terms) is the day I go back to playing the Lottery. And where is BugOil when one needs it...
wan: As Timbo points out you don't need a patent to commercialise your product, but you do need a patent to protect your product and stop others using it. Given the efforts deployed by the likes of Marks to have the patent refused, one assumes he has more than a personal vendetta with PI (given the management changes at PI), so we can assume he wants to use the product, which also tells us it's a great product. However, things have moved on! Whilst the likes of Marks has focused on the current technology, PI has been developing a new and improved technology and subsequently filed a patent application (which Marks cannot yet see!). Most readers will now know that the new technology has already launched as Fortalis, which importantly has already undergone extensive field testing. The results and data has resulted in the extension of Plant Impact's ongoing business relationship with Bayer CropScience, this technology validation via extensive field trials and Bayers further commitment (to both Fortalis and Veritas) says far more than Mark's can attempt to imply on here (or elsewhere). From the recent RNS - "This new foliar spray is Plant Impact's first formulated product to use the second generation of the Group's CaT(TM) technology, which has been developed over recent years, tested successfully in Argentina, Brazil and the United States and is subject to a pending patent application. " Obviously I expect PI to present further evidence (probably close to the 4 months time limit), which obviously could address the issues, especially as they have been precisely and clearly laid out, and at the very least, presenting further evidence will extend the process to the continued frustration of the likes of Mark's! In the meantime and in any regard, PI will continue to commercialise products that use the original technology, which as Timbo also highlights, is about more than what is contained in the patent itself e.g. actual in field testing and yield data and not to mention PI's secret formulation, which the patent does not reveal. Bayer's patent knowledge and indeed dedicated IP staff, will have also taken the situation into account before committing to both the current and new technology, and I would also draw readers attention to the following from the 'initial' commercial agreement with Bayer - "The parties have agreed to an initial, multi-year sales and production forecast and to various commercial and intellectual property responsibilities under the agreement. The financial details were not disclosed. " Notably then and six months later, PI announced a significant additional agreement with Bayer, which again actually says much more than the likes of Mark's can ever hope to say or imply. In short and in my view, efforts from the likes of Mark's will prove to have been ineffectual to PI's success!
horace_h: Dear Me. We could always count on you to snipe and post only bad news when the share price was in the low teens and you've been quiet until the recent bouncing of the share price around the current value. As with most posters on this good board, Wan has been balanced and attended the Investor days when able. Similarly, Here and There has been a measure of both good and bad and acknowledged the need for "the next leg up" with the introduction of the wheat product as the required catalyst for another leg up in the share price. If Dr Adams and his team can't deliver then we'll all no doubt reconsider where the share price will go. Thus far they have delivered on all that they said they would and PIM is not just a one trick pony based on the lucrative Veritas product - Banzai being one obvious addition to the previous portfolio. You're entirely free to promote your enduringly negative view but I do not think that Wan deserved that snide comment.
wan: Strange share price reaction, but one which has presented for another top-up opportunity for me.
wan: Good coverage here - 21st Mar 2016, by Plant Impact receives Brazil boost - unlike larger ag sector peers Plant Impact, unlike larger peers, dodged the bullet of soft Brazilian agricultural input markets to report a near-doubling in half-year earnings, for a period which saw too the launch of a cocoa yield promoter. Market reaction The results were termed "strong" by broker Peel Hunt, which restated a "buy" rating on Plant Impact shares, on which it has a price target of 70p. "The deals with Bayer and Arysta provide the company with the opportunity to build material revenue streams in two key global crops," said Peel Hunt analyst Charles Hall. "There is potential for significant additional upside to our target [share] price as the company delivers on new products and markets." Full story -
wan: In response to a few worries expressed on here, all I would say is that my personal horizons are too far out to worry about share price gyrations, which I have only ever used to top up, as opposed to top slice! The recent and extended deal with Bayer, to align PI's product pipeline in soy with the full solution of Bayer CropScience, looks to be hopefully only one, of what will prove to be several such deals. In other words, such deals for 'one' row crop are not based on flimsy scientific evidence or a weak pipeline, nor are such deals attached to attractive upfront and milestone payments if there is not good merit, indeed as this one is. Furthermore, PI's market approach (and potential), science and product pipeline are no doubt having an effect in attracting key individuals with excellent knowledge, experience and networks, the effect of which will no doubt be evident in the not too distant future. On top of this we have a management team that is very experienced and prudent and has delivered on the stated strategy. Keep in mind how disease resistance (cue Soybean Rust), not to mention patent expiry on existing products, can be overcome by combining products to very good effect both on and off the field! And then think how that could ultimately play out beyond Brazil's borders. Hence, I remain confident about PI's future and ultimate trajectory.
wan: Pleased to see that the CEO made a 'measured and judicious' share purchase, which underscores my assessment that the share price fall was perhaps providing opportunity. I see no change to the, ultimately, upward trajectory in PI's business, the product pipeline and prospects are both healthy, and one assumes the CEO thinks so too!
bigglesbingham: Hi Alan , your saying Brazil concerns you but results from Brazil are only just filtering into the share price. It's not as though share price has been reliant on Brazil for a number of years and profits just starting to drop off. I think the key here is the quality of management and research appointments . Dyor but their expertise is unquestioned and top managements ultimate remuneration is linked to share price performance .
cisk: Hi Wan tbh I'm not really that worked up about the incentives - if one stayed away from companies that gave 'large' rewards to CEOs for performance, then you'd miss out on some great performances over the years. D S Smith for example has more than doubled in a handful of years, and there was great disquiet about CEO packages there I seem to recall. Similar at WPP - which over several decades went from being a tiny wire making company to one of the world's biggest advertising conglomerates. Anyway I digress - as long as the share price continues its upward momentum during the period allowed for option vesting, I'm happy. It's when option prices are re-based downwards to reflect poor performance (in terms of share price, management and / or profits) I tend to sell. I would hope that this continues on its independent way for some time yet; I've only dipped my toe in the water and will continue slowly building a stake. I'm happy being patient and taking a 5 year view on this one - realise that most want a quick return (who wouldn't after all!) but quite happy to sit in there for longer-term gains.
Plant Impact share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170225 20:48:08